Ugo di Francesco

Ugo di Francesco

Director/Board Member at LABOMAR S.P.A.
66 year
Health Technology
Consumer Services
Commercial Services

Profile

Ugo di Francesco is currently Chief Executive Officer at Kedrion SpA since 2023, Chief Executive Officer at Bio Products Laboratory Ltd., Director at Farmindustria SA, Non-Executive Director at Labomar SpA, Director at Chiesi Ltd. since 2012, Director at CHIESI BV, Independent Director at Almirall SA since 2024, Director at Kedrion Holding SpA, and Member of the International Federation of Pharmaceutical Manufacturers.
Former roles include Chief Executive Officer & Vice President at Sigma-Tau Industrie Farmaceutiche Riunite SpA from 2007 to 2011, Chief Executive Officer & Director at CHIESI Farmaceutici SpA, Chief Executive Officer at Novartis Consumer Health SpA, Vice President at Amgen, Inc., Principal at Novartis sro, and Vice President-Pharmaceuticals Division at Bristol-Myers Squibb Srl.
Education includes an MBA from Bologna Business School.

Ugo di Francesco active positions

CompaniesPositionStart
LABOMAR S.P.A. Director/Board Member -
ALMIRALL, S.A. Director/Board Member 2024-10-04
Director/Board Member 2012-03-05
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member -
Chief Executive Officer 2022-12-31
Director/Board Member -
Chief Executive Officer -

Former positions of Ugo di Francesco

CompaniesPositionEnd
░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Ugo di Francesco's experience

Training of Ugo di Francesco

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

  1. Stock Market
  2. Insiders
  3. Ugo di Francesco